Vyant Bio Inc. buy tamam
Start price
07.12.17
/
50%
€303.08
Target price
07.12.18
€811.80
Performance (%)
-90.00%
End price
07.12.18
€30.30
Summary
This prediction ended on 07.12.18 with a price of €30.30. The BUY prediction by tamam for Vyant Bio Inc. performed very badly with a performance of -90.00%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by tamam for this prediction
In the thread Cancer Genetics Inc. diskutieren
tamam stimmt der Buy-Einschätzung von melinda zu
tamam stimmt am 07.12.2017 der Buy-Einschätzung von melinda aber mit dem Kursziel 6 $ zu.
Überschrift: diagnostics
Cancer Genetics (NASDAQ:CGIX) initiated with Buy rating and $6 (179% upside) price target by Maxim Group.
(Laufzeit überschritten)